The worlds largest commercial pharma event

October 11-13, 2022 | France

The worlds
We’ve entered a new era. One where being risk averse is the riskiest strategy, long-established operating models have been torn up and reimagined,

Spotlight

PCRI’s Executive Director, Mark Scholz, MD, gives an overview of active surveillance, a monitoring strategy for men with low-grade prostate cancer. He talks about why it is done, who is eligible and how it is performed.


OTHER PAST CONFERENCES

Pharma 2022

October 11-13, 2022 | France

Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing, risking a return to the old model plagued by persistent health disparities.

World Drug Safety Congress Europe

September 27-29, 2022 | USA

The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions.

East West BioPharma Summit

November 14-16, 2022 | USA

BioCentury and BayHelix invite you to Register Now to join us at the East-West BioPharma Summit at the Grand Bay Hotel San Francisco, Redwood City, CA on Nov. 14-16, 2022.

20th International Conference on Pharmaceutical Medicine

October 19-21, 2022 | Greece

2022 is a special year. We will be celebrating the long-awaited return of the 20th ICPM since the last one in 2018. It will also be the first time that ICPM will be accessible both on-site and on-line, ensuring you can access the very latest science and research updates, from wherever you are.

Spotlight

PCRI’s Executive Director, Mark Scholz, MD, gives an overview of active surveillance, a monitoring strategy for men with low-grade prostate cancer. He talks about why it is done, who is eligible and how it is performed.

resources